Article and Video CATEGORIES

Cancer Journey

Search By

Dr. Jack West is a medical oncologist and thoracic oncology specialist who is the Founder and previously served as President & CEO, currently a member of the Board of Directors of the Global Resource for Advancing Cancer Education (GRACE)

 

US Smoking Patterns over Time
Author
Howard (Jack) West, MD

In Seattle, we just had an evening program for lung cancer awareness that included issues in lung cancer largely focused on rectifying the disparity in lung cancer funding and awareness compared with other cancers, but also on tobacco control and screening. One of the talks was by a pulmonologist colleague from the University of Washington, Dr. Jason Chien, who highlighted several notable points on smoking patterns and how they are related to risk of lung cancer.

The first point is that while we talk a lot about never-smokers with lung cancer, tobacco is still by far the most important risk factor contributing to lung cancer. Here's a list of other variables, which pale in their impact compared to tobacco ("relative risk" means the multiplier compared to someone without a risk factor, so a relative risk of 2 means that a person with that exposure has twice the risk of somoene without it):

Epidemiologic Risk Factors for Lung Cancer

Tragically, unlike most or perhaps all other deadly diseases in the world, lung cancer has a major industry promoting the exposure to this deadly risk factor:

Smoking and Tobacco Lobby

Despite this force, smoking patterns have been declining over time, particularly in states in which there are stronger smoking cessation efforts, and less so in states that rely on tobacco as a leading component of their economy. Overall, it's about 20% overall and gradually declining over time:

Smoking Trends in US

This is largely because many people are quitting successfully, but as a side effect, there are growing ranks of ex-smokers in the US, now approaching 50 million. Fortunately, this has been associated with a significant decline in lung cancer deaths among men, and the start of a decline in lung cancer deaths now among women, who overall took up smoking later than men and have been a little slower to quit -- we hope the curves for women follow the decline seen in men over the next few decades:

US SMoking Trends 1900-2002

Next, we'll turn to how much and how quickly the risk of smoking declines after a person quits smoking.

Next Previous link

Previous PostNext Post

Related Content

Article
Advance directives are a powerful way to take control of healthcare choices. These documents allow you to outline preferences for medical care and specify end-of-life wishes. These documents can also be a way to appoint loved ones who you would like to help with these decisions, such as a healthcare proxy (someone to make decisions on your behalf, if you cannot). As cancer treatments can involve aggressive treatments and/or complex medical management, having advance directives ensures that your desires regarding treatment options and end-of-life care are clearly communicated. 
Image
2024-25 patient perspectives header
Article
Tell your story and help us help others! Apply online now for this paid opportunity. This program gives a voice to those who have experience in participating in a clinical trial for a cancer diagnosis. Your voice helps to educate and advocate for others who are in or who may be considering a clinical trial.  We want to hear from you!
Image
Foro de Pacientes de Terapias Dirigidas de Cáncer de Pulmón
Video
¡El vídeo completo bajo demanda está disponible para verlo!

Forum Discussions

Hi elysianfields and welcome to Grace.  I'm sorry to hear about your father's progression. 

 

Unfortunately, lepto remains a difficult area to treat.  Recently FDA approved the combo Lazertinib and Amivantamab...

Hello Janine, thank you for your reply.

Do you happen to know whether it's common practice or if it's worth taking lazertinib without amivantamab? From all the articles I've come across...

Hi elysianfields,

 

That's not a question we can answer. It depends on the individual's health. I've linked the study comparing intravenous vs. IV infusions of the doublet lazertinib and amivantamab...

Recent Comments

JOIN THE CONVERSATION
I could not find any info on…
By JanineT GRACE … on
Hi elysianfields,

 

That's…
By JanineT GRACE … on
Hello Janine, thank you for…
By elysianfields on
EGFR
By happybluesun on